Author: Julian Braun; Lucie Loyal; Marco Frentsch; Daniel Wendisch; Philipp Georg; Florian Kurth; Stefan Hippenstiel; Manuela Dingeldey; Beate Kruse; Florent Fauchere; Emre Baysal; Maike Mangold; Larissa Henze; Roland Lauster; Marcus Mall; Kirsten Beyer; Jobst Roehmel; Juergen Schmitz; Stefan Miltenyi; Marcel A Mueller; Martin Witzenrath; Norbert Suttorp; Florian Kern; Ulf Reimer; Holger Wenschuh; Christian Drosten; Victor M Corman; Claudia Giesecke-Thiel; Leif-Erik Sander; Andreas Thiel
Title: Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors Document date: 2020_4_22
ID: 164yx77a_34
Snippet: against SARS-CoV-2 currently remains unknown. Antibodies against HCoV can wane within 188 months after infection, although HCoV re-infection is accompanied by low-level and short-189 lived virus shedding with only mild symptoms of short duration 12 pointing towards residual 190.....
Document: against SARS-CoV-2 currently remains unknown. Antibodies against HCoV can wane within 188 months after infection, although HCoV re-infection is accompanied by low-level and short-189 lived virus shedding with only mild symptoms of short duration 12 pointing towards residual 190
Search related documents:
Co phrase search for related documents- HCoV antibody and low level: 1
- HCoV antibody and mild symptom: 1
- HCoV infection and low level: 1, 2
- live virus and low level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- live virus and short duration: 1, 2, 3, 4, 5
- live virus and unknown remain: 1
- low level and mild symptom: 1
- low level and short duration: 1, 2
- low level and unknown remain: 1
- mild symptom and short duration: 1
- mild symptom and unknown remain: 1
- short duration and unknown remain: 1, 2
Co phrase search for related documents, hyperlinks ordered by date